Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

Low doses of anti-CD3, ciclosporin A and the vitamin D analogue, TX527, synergise to delay recurrence of autoimmune diabetes in an islet-transplanted NOD mouse model of diabetes.

Baeke F, Van Belle TL, Takiishi T, Ding L, Korf H, Laureys J, Gysemans C, Mathieu C.

Diabetologia. 2012 Oct;55(10):2723-2732. doi: 10.1007/s00125-012-2630-1. Epub 2012 Jul 3.

PMID:
22752077
2.

Depleting anti-CD4 monoclonal antibody cures new-onset diabetes, prevents recurrent autoimmune diabetes, and delays allograft rejection in nonobese diabetic mice.

Makhlouf L, Grey ST, Dong V, Csizmadia E, Arvelo MB, Auchincloss H Jr, Ferran C, Sayegh MH.

Transplantation. 2004 Apr 15;77(7):990-7.

PMID:
15087759
3.

Treatment of autoimmune diabetes recurrence in non-obese diabetic mice by mouse interferon-beta in combination with an analogue of 1alpha,25-dihydroxyvitamin-D3.

Gysemans C, Van Etten E, Overbergh L, Verstuyf A, Waer M, Bouillon R, Mathieu C.

Clin Exp Immunol. 2002 May;128(2):213-20.

4.

Nondepleting anti-CD4 and soluble interleukin-1 receptor prevent autoimmune destruction of syngeneic islet grafts in diabetic NOD mice.

Drage M, Zaccone P, Phillips JM, Nicoletti F, Dawson J, Andrew Bradley J, Cooke A.

Transplantation. 2002 Sep 15;74(5):611-9.

PMID:
12352875
5.

Prevention of autoimmune destruction of syngeneic islet grafts in spontaneously diabetic nonobese diabetic mice by a combination of a vitamin D3 analog and cyclosporine.

Casteels K, Waer M, Laureys J, Valckx D, Depovere J, Bouillon R, Mathieu C.

Transplantation. 1998 May 15;65(9):1225-32.

PMID:
9603172
6.
7.

Remission and pancreas isograft survival in recent onset diabetic NOD mice after treatment with low-dose anti-CD3 monoclonal antibodies.

Mottram PL, Murray-Segal LJ, Han W, Maguire J, Stein-Oakley AN.

Transpl Immunol. 2002 Jun;10(1):63-72.

PMID:
12182467
8.

Anti-TCR mAb induces peripheral tolerance to alloantigens and delays islet allograft rejection in autoimmune diabetic NOD mice.

Deng R, Khattar M, Xie A, Schroder PM, He X, Chen W, Stepkowski SM.

Transplantation. 2014 Jun 27;97(12):1216-24. doi: 10.1097/TP.0000000000000120.

PMID:
24854475
9.

Analogs of 1alpha,25-dihydroxyvitamin D3 as pluripotent immunomodulators.

Van Etten E, Decallonne B, Verlinden L, Verstuyf A, Bouillon R, Mathieu C.

J Cell Biochem. 2003 Feb 1;88(2):223-6. Review.

PMID:
12520518
10.

Immunomodulatory properties of a 1,25(OH)(2) vitamin D(3) analog combined with IFNbeta in an animal model of syngeneic islet transplantation.

van Etten E, Gysemans C, Verstuyf A, Bouillon R, Mathieu C.

Transplant Proc. 2001 May;33(3):2319. No abstract available.

PMID:
11377545
11.

BCG immunotherapy prevents recurrence of diabetes in islet grafts transplanted into spontaneously diabetic NOD mice.

Lakey JR, Singh B, Warnock GL, Rajotte RV.

Transplantation. 1994 Apr 27;57(8):1213-7.

PMID:
8178349
12.
13.

Both CD4+ and CD8+ T-cells in syngeneic islet grafts in NOD mice produce interferon-gamma during beta-cell destruction.

Suarez-Pinzon W, Rajotte RV, Mosmann TR, Rabinovitch A.

Diabetes. 1996 Oct;45(10):1350-7.

PMID:
8826970
14.

Inhibition of autoimmune diabetes by oral administration of anti-CD3 monoclonal antibody.

Ishikawa H, Ochi H, Chen ML, Frenkel D, Maron R, Weiner HL.

Diabetes. 2007 Aug;56(8):2103-9. Epub 2007 Apr 24.

15.
16.

CD3 antibody treatment stimulates the functional capability of regulatory T cells.

Chatenoud L.

Novartis Found Symp. 2003;252:279-86; discussion 286-90. Review.

PMID:
14609225
17.

In vitro xenorecognition of adult pig pancreatic islet cells by splenocytes from nonobese diabetic or non-diabetes-prone mice.

Rivereau AS, You S, Lalain S, Gouin E, Saï P.

Transplantation. 1998 Sep 15;66(5):633-8.

PMID:
9753345
18.

Adoptive cell therapy using antigen-specific CD4⁻CD8⁻T regulatory cells to prevent autoimmune diabetes and promote islet allograft survival in NOD mice.

Zhang D, Zhang W, Ng TW, Wang Y, Liu Q, Gorantla V, Lakkis F, Zheng XX.

Diabetologia. 2011 Aug;54(8):2082-92. doi: 10.1007/s00125-011-2179-4. Epub 2011 May 19.

PMID:
21594554
19.

Modulation of antigen-specific T cell response by a non-mitogenic anti-CD3 antibody.

Li J, Davis J, Bracht M, Carton J, Armstrong J, Gao W, Scallon B, Fung R, Emmell E, Zimmerman M, Griswold DE, Li L.

Int Immunopharmacol. 2006 Jun;6(6):880-91. Epub 2006 Jan 27.

PMID:
16644473
20.

Supplemental Content

Support Center